cswi-20191231
FALSE2020Q30001624794--03-31P5YP2YP2Y00016247942019-04-012019-12-31xbrli:shares00016247942020-01-30iso4217:USD00016247942019-10-012019-12-3100016247942018-10-012018-12-3100016247942018-04-012018-12-31iso4217:USDxbrli:shares00016247942019-12-3100016247942019-03-310001624794us-gaap:CommonStockMember2019-03-310001624794us-gaap:TreasuryStockMember2019-03-310001624794us-gaap:AdditionalPaidInCapitalMember2019-03-310001624794us-gaap:RetainedEarningsMember2019-03-310001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001624794us-gaap:AdditionalPaidInCapitalMember2019-04-012019-06-3000016247942019-04-012019-06-300001624794us-gaap:CommonStockMember2019-04-012019-06-300001624794us-gaap:TreasuryStockMember2019-04-012019-06-300001624794us-gaap:AccountingStandardsUpdate201602Memberus-gaap:RetainedEarningsMember2019-04-010001624794us-gaap:AccountingStandardsUpdate201602Member2019-04-010001624794us-gaap:RetainedEarningsMember2019-04-012019-06-300001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-06-300001624794us-gaap:CommonStockMember2019-06-300001624794us-gaap:TreasuryStockMember2019-06-300001624794us-gaap:AdditionalPaidInCapitalMember2019-06-300001624794us-gaap:RetainedEarningsMember2019-06-300001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-3000016247942019-06-300001624794us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-3000016247942019-07-012019-09-300001624794us-gaap:RetainedEarningsMember2019-07-012019-09-300001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012019-09-300001624794us-gaap:CommonStockMember2019-09-300001624794us-gaap:TreasuryStockMember2019-09-300001624794us-gaap:AdditionalPaidInCapitalMember2019-09-300001624794us-gaap:RetainedEarningsMember2019-09-300001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-3000016247942019-09-300001624794us-gaap:AdditionalPaidInCapitalMember2019-10-012019-12-310001624794us-gaap:TreasuryStockMember2019-10-012019-12-310001624794us-gaap:RetainedEarningsMember2019-10-012019-12-310001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-10-012019-12-310001624794us-gaap:CommonStockMember2019-12-310001624794us-gaap:TreasuryStockMember2019-12-310001624794us-gaap:AdditionalPaidInCapitalMember2019-12-310001624794us-gaap:RetainedEarningsMember2019-12-310001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001624794us-gaap:CommonStockMember2018-03-310001624794us-gaap:TreasuryStockMember2018-03-310001624794us-gaap:AdditionalPaidInCapitalMember2018-03-310001624794us-gaap:RetainedEarningsMember2018-03-310001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-03-3100016247942018-03-310001624794us-gaap:AdditionalPaidInCapitalMember2018-04-012018-06-3000016247942018-04-012018-06-300001624794us-gaap:TreasuryStockMember2018-04-012018-06-300001624794us-gaap:AccountingStandardsUpdate201616Memberus-gaap:RetainedEarningsMember2018-04-010001624794us-gaap:AccountingStandardsUpdate201616Member2018-04-010001624794us-gaap:AccountingStandardsUpdate201409Memberus-gaap:RetainedEarningsMember2018-04-010001624794us-gaap:AccountingStandardsUpdate201409Member2018-04-010001624794us-gaap:RetainedEarningsMember2018-04-012018-06-300001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-04-012018-06-300001624794us-gaap:CommonStockMember2018-06-300001624794us-gaap:TreasuryStockMember2018-06-300001624794us-gaap:AdditionalPaidInCapitalMember2018-06-300001624794us-gaap:RetainedEarningsMember2018-06-300001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-06-3000016247942018-06-300001624794us-gaap:AdditionalPaidInCapitalMember2018-07-012018-09-3000016247942018-07-012018-09-300001624794us-gaap:TreasuryStockMember2018-07-012018-09-300001624794us-gaap:RetainedEarningsMember2018-07-012018-09-300001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-07-012018-09-300001624794us-gaap:CommonStockMember2018-09-300001624794us-gaap:TreasuryStockMember2018-09-300001624794us-gaap:AdditionalPaidInCapitalMember2018-09-300001624794us-gaap:RetainedEarningsMember2018-09-300001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-09-3000016247942018-09-300001624794us-gaap:AdditionalPaidInCapitalMember2018-10-012018-12-310001624794us-gaap:TreasuryStockMember2018-10-012018-12-310001624794us-gaap:RetainedEarningsMember2018-10-012018-12-310001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-10-012018-12-310001624794us-gaap:CommonStockMember2018-12-310001624794us-gaap:TreasuryStockMember2018-12-310001624794us-gaap:AdditionalPaidInCapitalMember2018-12-310001624794us-gaap:RetainedEarningsMember2018-12-310001624794us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-3100016247942018-12-31cswi:segmentcswi:brand0001624794cswi:PetersenMetalsMember2019-04-022019-07-310001624794cswi:PetersenMetalsMember2019-04-022019-04-020001624794cswi:PetersenMetalsMember2019-07-012019-07-310001624794cswi:PetersenMetalsMemberus-gaap:CustomerListsMember2019-04-022019-04-020001624794cswi:PetersenMetalsMemberus-gaap:OrderOrProductionBacklogMember2019-04-022019-04-020001624794cswi:PetersenMetalsMember2019-04-020001624794cswi:MSDResearchIncMember2019-01-312019-01-310001624794cswi:MSDResearchIncMemberus-gaap:CustomerListsMember2019-01-312019-01-310001624794cswi:MSDResearchIncMemberus-gaap:TrademarksMember2019-01-312019-01-310001624794cswi:MSDResearchIncMemberus-gaap:TechnologyBasedIntangibleAssetsMember2019-01-312019-01-310001624794cswi:MSDResearchIncMember2019-01-310001624794us-gaap:DiscontinuedOperationsHeldforsaleMember2017-10-012017-12-310001624794us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2018-07-012018-09-300001624794us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2019-10-012019-12-310001624794us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2018-10-012018-12-310001624794us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2019-04-012019-12-310001624794us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2018-04-012018-12-310001624794us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2019-12-310001624794us-gaap:DiscontinuedOperationsDisposedOfBySaleMember2019-03-310001624794us-gaap:AccountingStandardsUpdate201602Memberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2019-04-010001624794cswi:IndustrialProductsMember2019-03-310001624794cswi:SpecialtyChemicalsMember2019-03-310001624794cswi:IndustrialProductsMember2019-04-012019-12-310001624794cswi:SpecialtyChemicalsMember2019-04-012019-12-310001624794cswi:IndustrialProductsMember2019-12-310001624794cswi:SpecialtyChemicalsMember2019-12-310001624794us-gaap:PatentsMember2019-04-012019-12-310001624794us-gaap:PatentsMember2019-12-310001624794us-gaap:PatentsMember2019-03-310001624794cswi:CustomerListsAndTrademarksMember2019-04-012019-12-310001624794cswi:CustomerListsAndTrademarksMember2019-12-310001624794cswi:CustomerListsAndTrademarksMember2019-03-310001624794us-gaap:NoncompeteAgreementsMember2019-04-012019-12-310001624794us-gaap:NoncompeteAgreementsMember2019-12-310001624794us-gaap:NoncompeteAgreementsMember2019-03-310001624794us-gaap:OtherIntangibleAssetsMember2019-04-012019-12-310001624794us-gaap:OtherIntangibleAssetsMember2019-12-310001624794us-gaap:OtherIntangibleAssetsMember2019-03-310001624794us-gaap:TrademarksAndTradeNamesMember2019-12-310001624794us-gaap:TrademarksAndTradeNamesMember2019-03-310001624794us-gaap:StockCompensationPlanMembercswi:EquityAndIncentiveCompensation2015PlanMember2019-12-310001624794us-gaap:EmployeeStockOptionMember2019-10-012019-12-310001624794us-gaap:RestrictedStockMember2019-10-012019-12-310001624794us-gaap:EmployeeStockOptionMember2019-04-012019-12-310001624794us-gaap:RestrictedStockMember2019-04-012019-12-310001624794us-gaap:EmployeeStockOptionMember2018-10-012018-12-310001624794us-gaap:RestrictedStockMember2018-10-012018-12-310001624794us-gaap:EmployeeStockOptionMember2018-04-012018-12-310001624794us-gaap:RestrictedStockMember2018-04-012018-12-310001624794us-gaap:EmployeeStockOptionMember2019-03-310001624794us-gaap:EmployeeStockOptionMember2019-12-310001624794us-gaap:RestrictedStockMember2019-03-310001624794us-gaap:RestrictedStockMember2019-12-310001624794us-gaap:PerformanceSharesMember2019-12-310001624794us-gaap:PerformanceSharesMember2019-03-31xbrli:pure0001624794srt:MinimumMemberus-gaap:PerformanceSharesMember2019-04-012019-12-310001624794us-gaap:PerformanceSharesMembersrt:MaximumMember2019-04-012019-12-310001624794us-gaap:PerformanceSharesMember2019-04-012019-12-310001624794us-gaap:RevolvingCreditFacilityMember2019-12-310001624794us-gaap:RevolvingCreditFacilityMember2019-03-310001624794cswi:SubsidiariesWhitmoreMemberus-gaap:SecuredDebtMember2019-12-310001624794cswi:SubsidiariesWhitmoreMemberus-gaap:SecuredDebtMember2019-03-310001624794us-gaap:RevolvingCreditFacilityMember2019-04-012019-12-310001624794cswi:RevolvingCreditFacilityAccordionFeatureMember2019-12-310001624794us-gaap:PrimeRateMemberus-gaap:RevolvingCreditFacilityMember2019-04-012019-12-310001624794us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMember2019-04-012019-12-310001624794cswi:SubsidiariesWhitmoreMemberus-gaap:SecuredDebtMember2019-04-012019-12-310001624794cswi:SubsidiariesWhitmoreMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:SecuredDebtMember2019-04-012019-12-310001624794srt:MinimumMember2019-04-012019-12-310001624794srt:MaximumMember2019-04-012019-12-31cswi:lease00016247942019-10-012019-10-310001624794us-gaap:InterestRateSwapMember2019-12-310001624794us-gaap:InterestRateSwapMember2019-03-310001624794us-gaap:InterestRateSwapMember2019-04-012019-12-310001624794us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2019-12-310001624794us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2019-03-310001624794cswi:ShareRepurchaseProgram2016Member2016-11-110001624794cswi:ShareRepurchaseProgram2016Member2016-11-112016-11-110001624794cswi:ShareRepurchaseProgram2016Member2018-10-012018-12-310001624794cswi:ShareRepurchaseProgram2016Member2018-04-012018-12-310001624794cswi:ShareRepurchaseProgram2016Member2016-11-112018-10-310001624794cswi:ShareRepurchaseProgram2018Member2018-11-070001624794cswi:ShareRepurchaseProgram2018Member2018-11-072018-11-070001624794cswi:ShareRepurchaseProgram2018Member2019-10-012019-12-310001624794cswi:ShareRepurchaseProgram2018Member2019-04-012019-12-310001624794cswi:ShareRepurchaseProgram2018Member2018-11-072019-12-3100016247942019-04-042019-04-040001624794us-gaap:SubsequentEventMember2020-01-102020-01-100001624794us-gaap:QualifiedPlanMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-04-012019-12-310001624794us-gaap:QualifiedPlanMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-08-012019-08-310001624794us-gaap:QualifiedPlanMemberus-gaap:PensionPlansDefinedBenefitMembercountry:US2019-09-012019-09-300001624794us-gaap:AccumulatedTranslationAdjustmentMember2019-09-300001624794us-gaap:AccumulatedTranslationAdjustmentMember2018-09-300001624794us-gaap:AccumulatedTranslationAdjustmentMember2019-10-012019-12-310001624794us-gaap:AccumulatedTranslationAdjustmentMember2018-10-012018-12-310001624794us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001624794us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001624794us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-09-300001624794us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-09-300001624794us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-10-012019-12-310001624794us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2018-10-012018-12-310001624794us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-10-012018-12-310001624794us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-310001624794us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-12-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-300001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-09-300001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2019-10-012019-12-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2018-10-012018-12-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001624794us-gaap:AccumulatedTranslationAdjustmentMember2019-03-310001624794us-gaap:AccumulatedTranslationAdjustmentMember2018-03-310001624794us-gaap:AccumulatedTranslationAdjustmentMember2019-04-012019-12-310001624794us-gaap:AccumulatedTranslationAdjustmentMember2018-04-012018-12-310001624794us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-03-310001624794us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-03-310001624794us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-04-012019-12-310001624794us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2018-04-012018-12-310001624794us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-04-012018-12-310001624794cswi:AccumulatedGainLossNetCashFlowHedgeParentOtherAdjustmentMember2019-04-012019-12-310001624794cswi:AccumulatedGainLossNetCashFlowHedgeParentOtherAdjustmentMember2018-04-012018-12-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-03-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-03-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2019-04-012019-12-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2018-04-012018-12-310001624794cswi:AccumulatedDefinedBenefitPlansAdjustmentPensionTerminationExpenseMember2019-04-012019-12-310001624794cswi:AccumulatedDefinedBenefitPlansAdjustmentPensionTerminationExpenseMember2018-04-012018-12-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-04-012019-12-310001624794us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-04-012018-12-310001624794cswi:BuildToOrderMembercswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMember2019-10-012019-12-310001624794cswi:BuildToOrderMembercswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMember2019-10-012019-12-310001624794cswi:BuildToOrderMemberus-gaap:OperatingSegmentsMember2019-10-012019-12-310001624794cswi:BuildToOrderMembercswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMember2019-04-012019-12-310001624794cswi:BuildToOrderMembercswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMember2019-04-012019-12-310001624794cswi:BuildToOrderMemberus-gaap:OperatingSegmentsMember2019-04-012019-12-310001624794cswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMembercswi:BookAndShipMember2019-10-012019-12-310001624794cswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMembercswi:BookAndShipMember2019-10-012019-12-310001624794us-gaap:OperatingSegmentsMembercswi:BookAndShipMember2019-10-012019-12-310001624794cswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMembercswi:BookAndShipMember2019-04-012019-12-310001624794cswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMembercswi:BookAndShipMember2019-04-012019-12-310001624794us-gaap:OperatingSegmentsMembercswi:BookAndShipMember2019-04-012019-12-310001624794cswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMember2019-10-012019-12-310001624794cswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMember2019-10-012019-12-310001624794us-gaap:OperatingSegmentsMember2019-10-012019-12-310001624794cswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMember2019-04-012019-12-310001624794cswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMember2019-04-012019-12-310001624794us-gaap:OperatingSegmentsMember2019-04-012019-12-310001624794cswi:BuildToOrderMembercswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMember2018-10-012018-12-310001624794cswi:BuildToOrderMembercswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMember2018-10-012018-12-310001624794cswi:BuildToOrderMemberus-gaap:OperatingSegmentsMember2018-10-012018-12-310001624794cswi:BuildToOrderMembercswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMember2018-04-012018-12-310001624794cswi:BuildToOrderMembercswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMember2018-04-012018-12-310001624794cswi:BuildToOrderMemberus-gaap:OperatingSegmentsMember2018-04-012018-12-310001624794cswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMembercswi:BookAndShipMember2018-10-012018-12-310001624794cswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMembercswi:BookAndShipMember2018-10-012018-12-310001624794us-gaap:OperatingSegmentsMembercswi:BookAndShipMember2018-10-012018-12-310001624794cswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMembercswi:BookAndShipMember2018-04-012018-12-310001624794cswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMembercswi:BookAndShipMember2018-04-012018-12-310001624794us-gaap:OperatingSegmentsMembercswi:BookAndShipMember2018-04-012018-12-310001624794cswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMember2018-10-012018-12-310001624794cswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMember2018-10-012018-12-310001624794us-gaap:OperatingSegmentsMember2018-10-012018-12-310001624794cswi:IndustrialProductsMemberus-gaap:OperatingSegmentsMember2018-04-012018-12-310001624794cswi:SpecialtyChemicalsMemberus-gaap:OperatingSegmentsMember2018-04-012018-12-310001624794us-gaap:OperatingSegmentsMember2018-04-012018-12-310001624794cswi:EliminationsAndReconcilingItemsMember2019-10-012019-12-310001624794cswi:EliminationsAndReconcilingItemsMember2018-10-012018-12-310001624794cswi:EliminationsAndReconcilingItemsMember2019-04-012019-12-310001624794cswi:EliminationsAndReconcilingItemsMember2018-04-012018-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________________________
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2019
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     .
Commission File No. 001-37454
CSW INDUSTRIALS, INC.
(Exact name of registrant as specified in its charter)

Delaware47-2266942
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
5420 Lyndon B. Johnson Freeway, Suite 500, Dallas, Texas
75240
(Address of principal executive offices)
(Zip Code)
(214884-3777
Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareCSWI Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ☒  Yes    ☐  No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    ☒  Yes    ☐  No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
Accelerated filer
Non-accelerated filer ☐
(Do not check if smaller reporting company)

Smaller reporting company
Emerging growth company
 
  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      Yes    ☒  No
As of January 30, 2020, there were 15,125,931 shares of the issuer’s common stock outstanding.



CSW INDUSTRIALS, INC.
FORM 10-Q

TABLE OF CONTENTS
Page
No.
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
  Item 6.




PART I — FINANCIAL INFORMATION
Item 1. Financial Statements.
CSW INDUSTRIALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

Three Months Ended December 31,Nine Months Ended December 31,
(Amounts in thousands, except per share amounts)2019201820192018
Revenues, net$83,716  $77,488  $287,373  $258,678  
Cost of revenues(46,025) (43,260) (155,043) (140,153) 
Gross profit37,691  34,228  132,330  118,525  
Selling, general and administrative expenses(27,203) (24,807) (81,398) (74,156) 
Operating income10,488  9,421  50,932  44,369  
Interest expense, net(286) (289) (1,086) (1,094) 
Other (expense) income, net(848) 336  (8,302) 1,157  
Income before income taxes9,354  9,468  41,544  44,432  
Provision for income taxes(2,072) (3,471) (10,099) (12,005) 
Income from continuing operations7,282  5,997  31,445  32,427  
Income (loss) from discontinued operations, net of tax26  (1,016) (148) (616) 
Net income$7,308  $4,981  $31,297  $31,811  
Basic earnings (loss) per common share:
Continuing operations$0.48  $0.39  $2.09  $2.09  
Discontinued operations  (0.06) (0.01) (0.04) 
Net income$0.48  $0.33  $2.08  $2.05  
Diluted earnings (loss) per common share:
Continuing operations$0.48  $0.39  $2.07  $2.07  
Discontinued operations  (0.07) (0.01) (0.04) 
Net income$0.48  $0.32  $2.06  $2.03  
See accompanying notes to condensed consolidated financial statements.
1


CSW INDUSTRIALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)


Three Months Ended
December 31,
Nine Months Ended
December 31,
(Amounts in thousands)2019201820192018
Net income$7,308  $4,981  $31,297  $31,811  
Other comprehensive income (loss):
Foreign currency translation adjustments1,699  (1,582) 1,288  (3,024) 
Cash flow hedging activity, net of taxes of $(55), $67, $82 and $(20), respectively
207  (254) (307) (2) 
Pension and other postretirement effects, net of taxes of $1, $(11), $(672) and $(17), respectively
(3) 41  2,527  63  
Other comprehensive income (loss)1,903  (1,795) 3,508  (2,963) 
Comprehensive income$9,211  $3,186  $34,805  $28,848  
See accompanying notes to condensed consolidated financial statements.
2


CSW INDUSTRIALS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Amounts in thousands, except per share amounts)December 31, 2019March 31, 2019
ASSETS
Current assets:
Cash and cash equivalents$39,884  $26,651  
Accounts receivable, net of allowance for doubtful accounts of $1,139 and $591, respectively
57,583  66,136  
Inventories, net57,269  51,429  
Prepaid expenses and other current assets3,843  7,030  
Current assets, discontinued operations46  21  
Total current assets158,625  151,267  
Property, plant and equipment, net of accumulated depreciation of $70,285 and $65,548, respectively
55,599  53,639  
Goodwill92,720  86,295  
Intangible assets, net49,420  50,466  
Other assets22,318  10,965  
Noncurrent assets, discontinued operations2,012    
Total assets$380,694  $352,632  
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable$17,704  $19,024  
Accrued and other current liabilities34,666  29,426  
Current portion of long-term debt561  561  
Current liabilities, discontinued operations348  161  
Total current liabilities53,279  49,172  
Long-term debt10,477  30,898  
Retirement benefits payable2,049  1,978  
Other long-term liabilities19,302  6,114  
Noncurrent liabilities, discontinued operations2,595  784  
Total liabilities87,702  88,946  
Equity:
Common shares, $0.01 par value
159  158  
Shares authorized – 50,000
Shares issued – 16,054 and 16,001, respectively
Preferred shares, $0.01 par value
    
Shares authorized and issued – 10,000 and 0, respectively
Additional paid-in capital47,013  46,633  
Treasury shares, at cost (929 and 962 shares, respectively)
(49,317) (49,964) 
Retained earnings302,358  277,588  
Accumulated other comprehensive loss(7,221) (10,729) 
Total equity292,992  263,686  
Total liabilities and equity$380,694  $352,632  
See accompanying notes to condensed consolidated financial statements.
3


CSW INDUSTRIALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(Unaudited)

(Amounts in thousands)Common StockTreasury SharesAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Equity
Balance at March 31, 2019$158  $(49,964) $46,633  $277,588  $(10,729) $263,686  
Share-based compensation—  —  1,213  —  —  1,213  
Stock activity under stock plans1  (793) —  —  —  (792) 
Adoption of ASC 842 Leases—  —  —  (400) —  (400) 
Net income—  —  —  15,204  —  15,204  
Dividends declared—  —  —  (2,041) —  (2,041) 
Other comprehensive loss, net of tax—  —  —  —  (43) (43) 
Balance at June 30, 2019$159  $(50,757) $47,846  $290,351  $(10,772) $276,827  
Share-based compensation—  —  1,196  —  —  1,196  
Net income—  —  —  8,783  —  8,783  
Dividends declared—  —  25  (2,040) —  (2,015) 
Other comprehensive income, net of tax—  —  —  —  1,648  1,648  
Balance at September 30, 2019$159  $(50,757) $49,067  $297,094  $(9,124) $286,439  
Share-based compensation—  —  1,367  —  —  1,367  
Stock activity under stock plans—  2,251  (3,434) —  —  (1,183) 
Repurchase of common shares—  (811) —  —  —  (811) 
Net income—  —  —  7,308  —  7,308  
Dividends declared—  —  13  (2,044) —  (2,031) 
Other comprehensive income, net of tax—  —  —  —  1,903  1,903  
Balance at December 31, 2019$159  $(49,317) $47,013  $302,358  $(7,221) $292,992  



4


CSW INDUSTRIALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(Unaudited)

(Amounts in thousands)Common StockTreasury SharesAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive LossTotal Equity
Balance at March 31, 2018$158  $(3,252) $42,684  $233,650  $(7,475) $265,765  
Share-based compensation—  —  929  —  —  929  
Repurchase of common shares—  (7,366) —  —  —  (7,366) 
Stock activity under stock plans—  (136) —  —  —  (136) 
Adoption of ASU 2016-16—  —  —  (1,232) —  (1,232) 
Adoption of ASC 606 Revenue—  —  —  (692) —  (692) 
Net income—  —  —  11,676  —  11,676  
Other comprehensive loss, net of tax—  —  —  —  (1,335) (1,335) 
Balance at June 30, 2018$158  $(10,754) $43,613  $243,402  $(8,810) $267,609  
Share-based compensation—  —  865  —  —  865  
Repurchase of common shares—  (23,466) —  —  —  (23,466) 
Stock activity under stock plans—  (29) —  —  —  (29) 
Net income—  —  —  15,155  —  15,155  
Other comprehensive income, net of tax—  —  —  —  167  167  
Balance at September 30, 2018$158  $(34,249) $44,478  $258,557  $(8,643) $260,301  
Share-based compensation—  —  1,098  —  —  1,098  
Stock activity under stock plans—  (866) —  —  —  (866) 
Repurchase of common shares—  (9,892) —  —  —  (9,892) 
Net Income—  —  —  4,981  —  4,981  
Other comprehensive loss, net of tax—  —  —  —  (1,795) (1,795) 
Balance at December 31, 2018$158  $(45,007) $45,576  $263,538  $(10,438) $253,827  

See accompanying notes to condensed consolidated financial statements.
5


CSW INDUSTRIALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended December 31,
(Amounts in thousands)20192018
Cash flows from operating activities:
Net income$31,297  $31,811  
Less: Loss from discontinued operations(148) (616) 
Income from continuing operations31,445  32,427  
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation6,008  5,599  
Amortization of intangible and other assets5,238  4,799  
Provision for inventory reserves183  822  
Provision for doubtful accounts837  126  
Share-based and other executive compensation3,776  2,893  
Net gain on disposals of property, plant and equipment(844) (2,854) 
Pension plan termination expense6,559    
Net pension benefit (156) (296) 
Realized deferred taxes (See Note 15)  10,419  
Net deferred taxes(369) (194) 
Changes in operating assets and liabilities:
Accounts receivable, net10,143  12,450  
Inventories(5,099) (7,676) 
Prepaid expenses and other current assets3,236  (2,263) 
Other assets20  293  
Accounts payable and other current liabilities(265) 1,755  
Retirement benefits payable and other liabilities(359) (19) 
Net cash provided by operating activities, continuing operations60,353  58,281  
Net cash used in operating activities, discontinued operations(442) (8,401) 
Net cash provided by operating activities 59,911  49,880  
Cash flows from investing activities:
Capital expenditures(7,595) (4,766) 
Proceeds from sale of assets1,239  3,291  
Proceeds from sale of assets held for investment  2,102  
Cash paid for acquisitions(11,837)   
Net cash (used in) provided by investing activities, continuing operations(18,193) 627  
Net cash provided by investing activities, discontinued operations  7,356  
Net cash (used in) provided by investing activities(18,193) 7,983  
Cash flows from financing activities:
Borrowings on lines of credit7,500  8,000  
Repayments of lines of credit(27,921) (20,421) 
Purchase of treasury shares(2,784) (41,755) 
Dividends paid to shareholder(6,088)   
Net cash used in financing activities(29,293) (54,176) 
Effect of exchange rate changes on cash and equivalents808  (769) 
Net change in cash and cash equivalents13,233  2,918  
Cash and cash equivalents, beginning of period26,651  11,706  
Cash and cash equivalents, end of period$39,884  $14,624  
See accompanying notes to condensed consolidated financial statements.
6


CSW INDUSTRIALS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

1.ORGANIZATION AND OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES

CSW Industrials, Inc. (“CSWI,” “we,” “our” or “us”) is a diversified industrial growth company with well-established, scalable platforms and domain expertise across two segments: Industrial Products and Specialty Chemicals. Our broad portfolio of leading products provides performance optimizing solutions to our customers. Our products include mechanical products for heating, ventilating, air conditioning and refrigeration (“HVAC/R”), sealants, architecturally-specified building products and high-performance specialty lubricants. Drawing on our innovative and proven technologies, we seek to deliver solutions to our professional customers that require superior performance and reliability. Our diverse product portfolio includes more than 100 highly respected industrial brands including RectorSeal No. 5® thread sealants, KOPR-KOTE® anti-seize lubricants, KATS Coatings®, Safe-T-Switch® condensate overflow shutoff devices, Air Sentry® breathers, Deacon® high temperature sealants and AC Leak Freeze® to stop refrigerant leaks.

Our products are well-known in the specific industries we serve and have a reputation for high quality and reliability. The markets that we serve include HVAC/R, architecturally-specified building products, general industrial, plumbing, energy, rail and mining.

Basis of Presentation

The condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2019 (“Quarterly Report”), include all revenues, costs, assets and liabilities directly attributable to CSWI and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”).

The condensed consolidated financial statements reflect all adjustments that are, in the opinion of management, necessary to present a fair statement of CSWI’s financial position as of December 31, 2019 and the results of operations for the three and nine month periods ended December 31, 2019 and 2018. All adjustments are of a normal and recurring nature. All significant intercompany balances and transactions have been eliminated in consolidation.

The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in CSWI’s Annual Report on Form 10-K for the fiscal year ended March 31, 2019 (the “Annual Report”).

Accounting Policies

We have consistently applied the accounting policies described in our Annual Report in preparing these condensed consolidated financial statements.  We have not made any changes in significant accounting policies disclosed in the Annual Report, with the exception of the lease accounting policy described below as a result of adopting the new lease standards.

LeasesWe determine if a contract is or contains a lease at inception by evaluating whether the contract conveys the right to control the use of an identified asset. Right-of-Use (“ROU”) assets and lease liabilities are initially recognized at the commencement date based on the present value of remaining lease payments over the lease term calculated using our incremental borrowing rate, unless the implicit rate is readily determinable. ROU assets represent the right to use an underlying asset for the lease term, including any upfront lease payments made and excluding lease incentives. Lease liabilities represent the obligation to make future lease payments throughout the lease term. The lease term includes renewal periods when we are reasonably certain to exercise the option to renew. The ROU asset is amortized over the expected lease term. Lease and non-lease components, when present on our leases, are accounted for separately. Leases with an initial term of 12 months or less are excluded from recognition in the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term. We have certain lease contracts with terms and conditions that provide for variability in the payment amount based on changes in facts or circumstances occurring after the commencement date. These variable lease payments are recognized in our condensed consolidated income statements as the obligation is incurred. As of December 31, 2019, we did not have material leases that imposed significant restrictions or covenants, material related party leases or sale-leaseback arrangements.

7


Accounting Developments

Pronouncements Implemented

In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-02, "Leases (Topic 842)," which has been subsequently amended with additional ASUs including ASU No. 2018-10 and ASU No. 2018-11 issued in July 2018, and ASU No. 2018-20 issued in December 2018, to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessee have not significantly changed from previous U.S. GAAP. This ASU is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018. Modified retrospective application is permitted with certain practical expedients. Early adoption is permitted. We adopted this standard effective April 1, 2019, using the modified retrospective approach for leases existing at or entered into before the effective date. As such, the cumulative effect of the implementation has been recorded to the opening balance of retained earnings in the period of adoption and prior periods have not been adjusted. Upon adoption, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing whether any contracts are leases or contain leases, lease classification and initial direct lease costs. We also elected the transition practical expedient to apply hindsight when determining the lease term and when assessing impairment of ROU assets at the adoption date, which allows us to update our assessments according to new information and changes in facts and circumstances that have occurred since lease inception. Adoption of this ASU resulted in recognition of ROU assets and lease liabilities of $16.9 million and $18.6 million, respectively, including leases classified as discontinued operations, as well as a reduction to opening retained earnings of $0.4 million, at the date of adoption. Refer to Note 8 for details of the impact of the adoption of this ASU.

In August 2017, the FASB issued ASU No. 2017-12, "Derivatives and Hedging (Topic 815): Targeted Improvements of Accounting for Hedging Activities." The purpose of this ASU is to better align a company's risk management activities and financial reporting for hedging relationships. Additionally, the ASU simplifies the hedge accounting requirements and improves the disclosures of hedging arrangements. This ASU was amended by ASU 2018-16 to include the secured overnight financing rate as an acceptable reference rate. This ASU is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2018. Adoption of this ASU effective April 1, 2019, did not have a material impact on our consolidated financial condition or results of operations.

Pronouncements not yet implemented

In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments," as amended, which requires, among other things, the use of a new current expected credit loss ("CECL") model in order to determine our allowances for doubtful accounts with respect to accounts receivable. The CECL model requires that we estimate our lifetime expected credit loss with respect to our receivables and contract assets and record allowances that, when deducted from the balance of the receivables, represent the net amounts expected to be collected. We will also be required to disclose information about how we developed the allowances, including changes in the factors that influenced our estimate of expected credit losses and the reasons for those changes. This ASU is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2019. We do not expect adoption of this ASU to have a material impact on our consolidated financial condition and results of operations.

In August 2018, the FASB issued ASU No. 2018-13, "Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement," which modifies the disclosure requirements on fair value measurements. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. An entity is permitted to early adopt any removed or modified disclosures and delay adoption of the additional disclosures until their effective date. This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. We do not expect adoption of this ASU to have a material impact on our consolidated financial condition and results of operations.

In August 2018, the FASB issued ASU No. 2018-14, "Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans," which modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The amendments remove disclosures that no longer are considered cost beneficial, clarify the specific requirements of disclosures and add disclosure requirements identified as relevant. This ASU is effective, on a
8


retrospective basis, for fiscal years ending after December 15, 2020. Early adoption is permitted. We do not expect adoption of this ASU to have a material impact on our consolidated financial condition and results of operations.

In August 2018, the FASB issued ASU No. 2018-15, "Customer's Accounting for the Implementation Costs Incurred in Cloud Computing Arrangement That is a Service Contract." The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). This ASU is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years, and should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. Early adoption is permitted. We do not expect adoption of this ASU to have a material impact on our consolidated financial condition and results of operations.

In December 2019, the FASB issued ASU No. 2019-12, "Income Taxes: Simplifying the Accounting for Income Taxes." The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions and adding some requirements regarding franchise (or similar) tax, step-ups in a business combination, treatment of entities not subject to tax and when to apply enacted changes in tax laws. This ASU is effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The amendments related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments related to franchise taxes that are partially based on income should be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments should be applied on a prospective basis. Early adoption is permitted. Our initial assessment of this ASU indicates it will not have a material impact on our consolidated financial condition and results of operations, but our assessment is not complete.

2. ACQUISITIONS

Petersen Metals

On April 2, 2019, we acquired the assets of Petersen Metals, Inc. (“Petersen”), based near Tampa, Florida, for $11.8 million, of which $11.5 million was paid at closing and funded through our revolving credit facility, and the remaining $0.3 million represented a working capital adjustment paid in July 2019. Petersen is a leading designer, manufacturer and installer of architecturally-specified, engineered metal products and railings, including aluminum and stainless steel railings products for interior and exterior applications. The excess of the purchase price over the fair value of the identifiable assets acquired was $6.1 million allocated to goodwill, which will be deductible for income tax purposes. Goodwill represents the value expected to be obtained from enabling geographic, end market and product diversification and expansion as Petersen is a strategic complement to our existing line of architecturally-specified building products. The preliminary allocation of the fair value of the net assets acquired included customer lists of $3.2 million and backlog of $0.4 million, as well as accounts receivable, inventory and equipment of $2.2 million, $0.8 million and $0.7 million, respectively, net of current liabilities of $1.5 million. Customer lists are being amortized over 15 years, backlog is amortized over 1.5 years and goodwill is not being amortized. Petersen activity has been included in our Industrial Products segment since the acquisition date. No pro forma information has been provided due to immateriality.

MSD Research, Inc.

On January 31, 2019, we acquired the assets of MSD Research, Inc. (“MSD”), based in Boca Raton, Florida, for $10.1 million, funded through our revolving credit facility. MSD is a leading provider of condensate management products for commercial and residential HVAC/R systems, including float switches, drain line cleanouts and flush tools. The excess of the purchase price over the fair value of the identifiable assets acquired was $5.2 million allocated to goodwill, which will be deductible for income tax purposes. Goodwill represents the value expected to be obtained from owning a more extensive condensation management product portfolio for the HVAC/R market and leveraging our larger distributor network. The preliminary allocation of the fair value of the net assets acquired included customer lists, trademarks and technology of $3.3 million, $0.8 million and $0.4 million, respectively, as well as inventory and accounts receivable of $0.3 million and $0.1 million, respectively. Customer lists and technology are being amortized over 10 years and 5 years, respectively, while trademarks and goodwill are not being amortized.  MSD activity has been included in our Industrial Products segment since the acquisition date. No pro forma information has been provided due to immateriality.

9


3. DISCONTINUED OPERATIONS

During the quarter ended December 31, 2017, we commenced a sale process to divest our Coatings business to allow us to focus resources on our core growth platforms. Our Coatings business manufactured specialized industrial coating products including urethanes, epoxies, acrylics and alkyds. As of December 31, 2017, the Coatings business met the held-for-sale criteria under ASC 360, "Property, Plant and Equipment," and accordingly, we classified and accounted for the assets and liabilities of the Coatings business as held-for-sale in the accompanying condensed consolidated balance sheets, and as discontinued operations, net of tax, in the accompanying condensed consolidated statements of income and cash flows. We completed an initial assessment of the assets and liabilities of the Coatings business and recorded a $46.0 million impairment based on our best estimates as of the date of issuance of financial results for the quarter ended December 31, 2017. No adjustments to previously recorded estimates have been made subsequently.

On July 31, 2018, we consummated a sale of assets related to our Coatings business to an unrelated third party, the terms of which were not disclosed due to immateriality. During the three months ended September 30, 2018, we received an aggregate of $6.9 million for the sale of assets related to our Coatings business in multiple transactions. This resulted in gains on disposal of $6.9 million due to write-downs of long-lived assets in prior periods.

Summarized selected financial information for the Coatings business for the three and nine months ended December 31, 2019 and 2018, is presented in the following table:

Three Months Ended
December 31,
Nine Months Ended
December 31,
(amounts in thousands)2019201820192018
Revenues, net$  $  $  $5,303  
Income (loss) from discontinued operations before income taxes19  (1,225) (204) (693) 
Income tax benefit7  209  56  77  
Income (loss) from discontinued operations, net$26  $(1,016) $(148) $(616) 

(amounts in thousands)December 31, 2019March 31, 2019
Assets
Prepaid expenses and other current assets (a)$  $21  
Other assets (b)2,012    
Total assets$2,012  $21  
Liabilities
Accounts payable, accrued expenses and other liabilities (b)$2,943  $945  

(a) The assets and liabilities of the Coatings business reside in a disregarded entity for tax purposes. Accordingly, the tax attributes associated with the operations of our Coatings business will ultimately flow through to the corporate parent, which files a consolidated federal return. Therefore, any corresponding tax assets or liabilities have been reflected as a component of our continuing operations.

(b) Adoption of the new lease standard resulted in recognition of ROU assets and lease liabilities of $1.8 million and $2.9 million, respectively, for the Coatings business. Refer to Note 8 for details and additional discussions on our adoption of the new lease standard.
10


4. INVENTORIES

Inventories consist of the following (in thousands):
December 31, 2019March 31, 2019
Raw materials and supplies$21,706  $20,267  
Work in process7,273  6,483  
Finished goods35,588  31,876  
Total inventories64,567  58,626  
Less: LIFO reserve(5,027) (5,027) 
Less: Obsolescence reserve(2,271) (2,170) 
Inventories, net$57,269  $51,429  

5. GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill as of December 31, 2019 and March 31, 2019 were as follows (in thousands):

Industrial ProductsSpecialty
Chemicals
Total
Balance at March 31, 2019$54,732  $31,563  $86,295  
Petersen acquisition6,128    6,128  
Currency translation297    297  
Balance at December 31, 2019$61,157  $31,563  $92,720  

The following table provides information about our intangible assets (in thousands, except years): 
December 31, 2019March 31, 2019
Wtd Avg Life (Years)Ending Gross AmountAccumulated AmortizationEnding Gross AmountAccumulated Amortization
Finite-lived intangible assets:
Patents11$9,636  $(6,735) $9,835  $(6,316) 
Customer lists and amortized trademarks1263,726  (32,231) 60,065  (28,622) 
Non-compete agreements51,782  (1,478) 1,764  (1,066) 
Other85,161  (2,465) 4,808  (2,010) 
$80,305  $(42,909) $76,472  $(38,014) 
Trade names and trademarks not being amortized:$12,024  $—  $12,008  $—  

Amortization expense for the three and nine months ended December 31, 2019 were $1.7 million and $5.1 million, respectively. Amortization expense for the three and nine months ended December 31, 2018, were $1.5 million and $4.6 million, respectively. The following table shows the estimated future amortization for intangible assets, as of December 31, 2019, for the remainder of the current fiscal year and the next five fiscal years ending March 31 (in thousands):

2020$1,360  
20215,504  
20225,100  
20234,244  
20243,938  
20253,250  

11


6. SHARE-BASED COMPENSATION

Refer to Note 6 to our consolidated financial statements included in the Annual Report for a description of the 2015 Equity and Incentive Compensation Plan (the "2015 Plan"). As of December 31, 2019, 771,543 shares were available for issuance under the 2015 Plan.

We recorded share-based compensation expense as follows for the three and nine months ended December 31, 2019 and 2018 (in thousands): 
Three Months Ended December 31, 2019Nine Months Ended December 31, 2019
Stock OptionsRestricted 
Stock
TotalStock OptionsRestricted 
Stock
Total
Share-based compensation expense$  $1,366  $1,366  $  $3,776  $3,776  
Related income tax benefit  (328) (328)   (906) (906) 
Net share-based compensation expense$  $1,038  $1,038  $  $2,870  $2,870  
Three Months Ended December 31, 2018Nine Months Ended December 31, 2018
Stock OptionsRestricted 
Stock
TotalStock OptionsRestricted 
Stock
Total
Share-based compensation expense$  $1,099  $1,099  $19  $2,874  $2,893  
Related income tax benefit  (264) (264) (4) (690) (694) 
Net share-based compensation expense$  $835  $835  $15  $2,184  $2,199  

Stock option activity was as follows:
Nine Months Ended December 31, 2019
Number of SharesWeighted Average Exercise PriceRemaining Contractual Life (Years)Aggregate Intrinsic Value (in Millions)
Outstanding at April 1, 2019:231,717  $25.12  
Exercised(115,859) 24.93  
Canceled    
Outstanding at December 31, 2019115,858  $25.30  4.376.0
Exercisable at December 31, 2019115,858  $25.30  4.376.0

All compensation costs related to stock options were recognized prior to April 1, 2019. No options were granted or vested during the three and nine months ended December 31, 2019 and 2018.

Restricted share activity was as follows: 
Nine Months Ended December 31, 2019
Number of SharesWeighted Average Grant Date Fair Value
Outstanding at April 1, 2019:213,622  $45.42  
     Granted89,584  71.13  
     Vested(96,312) 37.46  
     Canceled(4,113) 44.83  
Outstanding at December 31, 2019202,781  $60.57  

During the restriction period, the holders of restricted shares are entitled to vote and receive dividends. Unvested restricted shares outstanding as of December 31, 2019 and March 31, 2019 included 92,905 and 96,282 shares (at target), respectively, with performance-based vesting provisions, having vesting ranges from 0%-200% based on pre-defined performance targets with market conditions.  Performance-based awards accrue dividend equivalents, which are settled upon (and to the extent of) vesting of the underlying award, but do not have the right to vote until vested. Performance-based awards are earned upon the
12


achievement of objective performance targets and are payable in common shares.  Compensation expense is calculated based on the fair market value as determined by a Monte Carlo simulation and is recognized over a 36-month cliff vesting period.

At December 31, 2019, we had unrecognized compensation cost related to unvested restricted shares of $8.3 million, which will be amortized into net income over the remaining weighted average vesting period of approximately 2.0 years. The total fair value of restricted shares granted during the three months ended December 31, 2019 and 2018 was $3.8 million and $3.3 million, respectively. The total fair value of restricted shares granted during the nine months ended December 31, 2019 and 2018 was $6.4 million and $5.0 million, respectively. The total fair value of restricted shares vested during the three months ended December 31, 2019 and 2018 was $4.1 million and $2.2 million, respectively. The total fair value of restricted shares vested during the nine months ended December 31, 2019 and 2018 was $6.2 million and $2.6 million, respectively.

7. LONG-TERM DEBT

Debt consists of the following (in thousands):

December 31, 2019March 31, 2019
Revolving Credit Facility, interest rate of 3.01% and 3.74%, respectively
$  $20,000  
Whitmore Term Loan, interest rate of 3.76% and 4.50%, respectively
11,038  11,459  
Total debt11,038  31,459  
Less: Current portion(561) (561) 
Long-term debt$10,477  $30,898  

Revolving Credit Facility

As discussed in Note 8 to our consolidated financial statements included in our Annual Report, we have a five-year, $250.0 million revolving credit facility agreement, with an additional $50.0 million accordion feature, which matures on September 15, 2022 (the “Revolving Credit Facility”). Borrowings under this facility bear interest at a rate of prime plus 0.25% or London Interbank Offered Rate ("LIBOR") plus 1.25%, which may be adjusted based on our leverage ratio. We pay a commitment fee of 0.15% for the unutilized portion of the Revolving Credit Facility.  Interest and commitment fees are payable at least quarterly and the outstanding principal balance is due at the maturity date. The Revolving Credit Facility is secured by substantially all of our domestic assets. During the nine months ended December 31, 2019, we borrowed $7.5 million and repaid $27.5 million under this facility, and as of December 31, 2019 and March 31, 2019, we had a remaining outstanding balance of $0 and $20.0 million, respectively, which resulted in borrowing capacity of $300.0 million and $280.0 million, respectively, inclusive of the accordion feature. Covenant compliance is tested quarterly, and we were in compliance with all covenants as of December 31, 2019.

Whitmore Term Loan

As of December 31, 2019, Whitmore Manufacturing (one of our wholly-owned operating subsidiaries) had a secured term loan ("Whitmore Term Loan") outstanding related to a warehouse and corporate office building and the remodel of an existing manufacturing and research and development facility.  The Whitmore Term Loan matures on July 31, 2029 and requires payments of $140,000 each quarter. Borrowings under this loan bear interest at a variable annual rate equal to one month LIBOR plus 2.0%.  As of December 31, 2019 and March 31, 2019, Whitmore Manufacturing had $11.0 million and $11.5 million, respectively, in outstanding borrowings under the Whitmore Term Loan. Interest payments under the Whitmore Term Loan are hedged under an interest rate swap agreement as described in Note 9.

13


8. LEASES

We have operating leases for manufacturing facilities, offices, warehouses, vehicles and certain equipment. Our leases have remaining lease terms of 1 year to 10 years, some of which include escalation clauses and/or options to extend or terminate the leases. Leases related to discontinued operations have been omitted from the following disclosures (see Note 3 for information on leases included in discontinued operations).

In October 2019, we terminated two operating leases and paid an early lease termination fee of $0.5 million. The loss on early termination is recorded in other income (expense), net as the assets were not used in our operations.

We do not currently have any financing lease arrangements.

Three Months Ended December 31, 2019Nine Months Ended December 31, 2019
Components of Operating Lease Expenses (in thousands)
Operating lease expense (a)$846  $2,639  
Short-term lease expense (a)48  201  
Total operating lease expense  $894  $2,840  
(a)  Included in cost of revenues and selling, general and administrative expense
December 31, 2019
Operating Lease Assets and Liabilities (in thousands)
ROU assets, net (a)$14,683  
Short-term lease liabilities (b)$2,583  
Long-term lease liabilities (b)12,732  
Total operating lease liabilities$15,315  
(a) Included in other assets, net
(b) Included in accrued and other current liabilities and other long-term liabilities

Nine Months Ended December 31, 2019
Supplemental Cash Flow (in thousands)
Cash paid for amounts included in the measurement of operating lease liabilities (a)$2,554  
ROU assets obtained in exchange for new operating lease obligations2,419  
(a) Included in our condensed consolidated statement of cash flows, operating activities in accounts payable and other current liabilities
Other Information for Operating Leases
Weighted average remaining lease term (in years)6.24
Weighted average discount rate (percent)4.3 %

14


Maturities of operating lease liabilities were as follows (in thousands): 
Year Ending March 31, 2020 (excluding the nine months ended December 31, 2019)$828  
20213,256  
20223,235  
20232,569  
20242,349  
Thereafter6,011  
Total lease liabilities 18,248  
Less: Imputed interest(2,933) 
Present value of lease liabilities$15,315  

As discussed in Note 1, we elected the transition practical expedient to apply hindsight when determining the lease term at the new lease standard adoption date. The increase in lease liabilities at December 31, 2019, as compared with future obligations as of March 31, 2019, represents the renewal period options that we were reasonably certain to exercise as of the adoption date.

The future minimum obligations under operating leases in effect as of March 31, 2019 having a noncancellable term in excess of one year as determined prior to the adoption of the new lease standard are as follows for the fiscal years ending March 31 (in thousands):

2020$3,048  
20212,733  
20221,645  
20231,038  
2024921  
Thereafter1,010  
Total future minimum lease payments$10,395  

9. DERIVATIVE INSTRUMENTS AND HEDGE ACCOUNTING

We have an interest rate swap agreement to hedge exposure to floating interest rates on a certain portion of our debt.  As of December 31, 2019 and March 31, 2019, we had $11.0 million and $11.5 million, respectively, of notional amount outstanding designated as an interest rate swap with third parties.  The interest rate swap is highly effective. At December 31, 2019, the maximum remaining length of the interest rate swap contract was approximately 9.6 years. The fair value of the interest rate swap designated as a hedging instrument is summarized below (in thousands):

December 31, 2019March 31, 2019
Current derivative liabilities$137  $56  
Non-current derivative liabilities751  443  

The impact of changes in fair value of the interest rate swap is included in Note 16.

Current and non-current derivative assets are reported in our condensed consolidated balance sheets in prepaid expenses and other current assets and other assets, respectively. Current and non-current derivative liabilities are reported in our condensed consolidated balance sheets in accrued and other current liabilities and other long-term liabilities, respectively.

We are exposed to risk from credit-related losses resulting from nonperformance by counterparties to our financial instruments.  We perform credit evaluation of our counterparties and expect all counterparties to meet their obligations.  Through December 31, 2019, we have not experienced credit losses from our counterparties.

15


10. EARNINGS PER SHARE

The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted earnings per share for the three and nine months ended December 31, 2019 and 2018 (amounts in thousands, except per share data):

Three Months Ended
December 31,
Nine Months Ended
December 31,
2019201820192018
Income from continuing operations$7,282  $5,997  $31,445  $32,427  
Income (loss) from discontinued operations26  (1,016) (148) (616) 
Net income$7,308  $4,981  $31,297  $31,811  
Weighted average shares:
Common stock14,976  15,084  14,931  15,369  
Participating securities108  154  113  159  
Denominator for basic earnings per common share15,084  15,238  15,044  15,528  
Potentially dilutive securities168  115  177  117  
Denominator for diluted earnings per common share15,252  15,353  15,221  15,645  
Basic earnings (loss) per common share:
Continuing operations$0.48  $0.39  $2.09  $2.09  
Discontinued operations  (0.06) (0.01) (0.04) 
Net income$0.48  $0.33  $2.08  $2.05  
Diluted earnings (loss) per common share:
Continuing operations$0.48  $0.39  $2.07  $2.07  
Discontinued operations  (0.07) (0.01) (0.04) 
Net income$0.48  $0.32  $2.06  $2.03  
 

16


11. SHAREHOLDERS' EQUITY

Share Repurchase Program

On November 11, 2016, we announced that our Board of Directors authorized a program to repurchase up to $35.0 million of our common stock over a two-year time period. We purchased 57,499 and 629,659 shares during the three and nine months ended December 31, 2018, respectively, for an aggregate amount of $3.0 million and $33.8 million, respectively. As of October 31, 2018, a total of 656,203 shares had been repurchased for an aggregate amount of $35.0 million, and the program was completed.

On November 7, 2018, we announced that our Board of Directors authorized a new program to repurchase up to $75.0 million of our common stock over a two-year time period. These shares may be repurchased from time to time in the open market or in privately negotiated transactions. Repurchases will be made from time to time at our discretion, based on ongoing assessments of the capital needs of the business, the market price of our common stock and general market conditions. The program may be limited or terminated at any time at our discretion without notice. During the three and nine months ended December 31, 2019, 12,494 shares were purchased under this program for an aggregate amount of $0.8 million. As of December 31, 2019, a total of 243,644 shares had been repurchased for an aggregate amount of $12.6 million under this program.

Dividends

On April 4, 2019, we announced we had commenced a dividend program and that our Board of Directors approved a quarterly dividend of $0.135 per share. Total dividends of $2.0 million and $6.1 million were declared and paid during the three and nine months ended December 31, 2019, respectively. On January 10, 2020, we announced a quarterly dividend of $0.135 per share payable on February 14, 2020 to shareholders of record as of January 31, 2020. Any future dividends at the existing $0.135 per share quarterly rate or otherwise will be reviewed individually and declared by our Board of Directors in its discretion.

12. FAIR VALUE MEASUREMENTS

The fair value of the interest rate swap contract (as discussed in Note 9) is determined using Level 2 inputs.  The carrying value of our debt (discussed in Note 7) approximates fair value as it bears interest at floating rates.  The carrying amounts of other financial instruments (i.e., cash and cash equivalents, accounts receivable, net, accounts payable) approximate their fair values at December 31, 2019 and March 31, 2019 due to their short-term nature.

13. RETIREMENT PLANS
Refer to Note 13 to our consolidated financial statements included in the Annual Report for a description of our retirement and post-retirement benefits.

The following tables set forth the combined net pension benefit recognized in our condensed consolidated financial statements for all plans (in thousands):
Three Months Ended
December 31,
Nine Months Ended
December 31,
2019201820192018
Service cost, benefits earned during the period$18  $19  $53  $56  
Interest cost on projected benefit obligation37  528  1,082  1,584  
Expected return on assets(27) (664) (1,334) (1,991) 
Amortization of net actuarial loss12  12  38  36  
Pension plan termination    7,019    
Net pension benefit$40  $(105) $6,858  $(315) 

The components of net periodic cost for retirement and postretirement benefits, other than service costs, are included in other (expense) income, net in our condensed consolidated statements of income.

During the nine months ended December 31, 2019, we offered lump sum payments to eligible active and terminated vested participants in our qualified U.S. pension plan (the “Qualified Plan”), representing approximately 42% of our liability.
17


Approximately 74% of those participants accepted the lump sum offer for an aggregate payment of $17.0 million in August 2019. We entered into an annuity purchase contract for the remaining liability in September 2019, and terminated the Qualified Plan effective September 30, 2019. The termination required an additional contribution of $0.5 million, which was paid in September 2019, and resulted in an overall termination charge of $7.0 million ($5.4 million, net of tax) recorded in other (expense) income, net, due primarily to the recognition of expenses that were previously included in accumulated other comprehensive loss and the recognition of additional costs associated with the annuity purchase contract.

14. CONTINGENCIES

From time to time, we are involved in various claims and legal actions that arise in the ordinary course of business.  There are no matters pending that we currently believe have a reasonable possibility of having a material impact to our business, consolidated financial position, results of operations or cash flows.

15. INCOME TAXES

For the three months ended December 31, 2019, we earned $9.4 million from continuing operations before taxes and provided for income taxes of $2.1 million, resulting in an effective tax rate of 22.2%. For the nine months ended December 31, 2019, we earned $41.5 million from continuing operations before taxes and provided for income taxes of $10.1 million, resulting in an effective tax rate of 24.3%. The provision for income taxes differed from the statutory rate for the three and nine months ended December 31, 2019, primarily due to the provision for global intangible low-taxed income ("GILTI"), adjustments related to foreign items, excess tax deductions related to stock compensation, and adjustments related to income tax returns.

For the three months ended December 31, 2018, we earned $9.5 million from continuing operations before taxes and provided for income taxes of $3.5 million, resulting in an effective tax rate of 36.7%. For the nine months ended December 31, 2018, we earned $44.4 million from continuing operations before taxes and provided for income taxes of $12.0 million, resulting in an effective tax rate of 27.0%. The provision for income taxes differed from the statutory rate for the three and nine months ended December 31, 2018, primarily due to adjustments related to federal and foreign income tax returns.

As the assets and liabilities of our discontinued Coatings business discussed in Note 3 reside in a disregarded entity for tax purposes, the tax attributes associated with the operations of our Coatings business ultimately flow through to our corporate parent, which files a consolidated federal return. Therefore, corresponding deferred tax assets or liabilities expected to be substantially realized by our corporate parent have been reflected as assets of our continuing operations and have not been allocated to the balances of assets or liabilities of our discontinued operations disclosed in Note 3. The statement of cash flows reflects the impact of the deferred taxes related to the disregarded entity in Realized deferred taxes (prior year has been conformed to our current presentation).

18


16. OTHER COMPREHENSIVE INCOME (LOSS)

The following table provides an analysis of the changes in accumulated other comprehensive loss (in thousands):

Three Months Ended
December 31,
20192018
Currency translation adjustments:
Balance at beginning of period$(7,280) $(6,279) 
Adjustments for foreign currency translation1,699  (1,582) 
Balance at end of period$(5,581) $(7,861) 
Interest rate swaps:
Balance at beginning of period$(908) $144  
Unrealized gains (losses), net of taxes of $(49) and $71, respectively (a)
184  (268) 
Reclassification of losses included in interest expense, net,
  net of taxes of $(6) and $(4), respectively
23  14  
Other comprehensive income (loss)207  (254) 
Balance at end of period$(701) $(110) 
Defined benefit plans:
Balance at beginning of period$(936) $(2,508) 
Amortization of net (losses) gains, net of taxes of $1 and $(11),
  respectively (b)
(3) 41  
Balance at end of period$(939) $(2,467) 

19


Nine Months Ended
December 31,
20192018
Currency translation adjustments:
Balance at beginning of period$(6,869) $(4,837) 
Adjustments for foreign currency translation1,288  (3,024) 
Balance at end of period$(5,581) $(7,861) 
Interest rate swaps:
Balance at beginning of period$(394) $(108) 
Unrealized losses, net of taxes of $94 and $11, respectively (a)
(354) (42) 
Reclassification of losses included in interest expense, net,
  net of taxes of $(12) and $(15), respectively
47  56  
Other adjustments (c)  (16) 
Other comprehensive loss(307) (2) 
Balance at end of period$(701) $(110) 
Defined benefit plans:
Balance at beginning of period$(3,466) $(2,530) 
Amortization of net gains, net of taxes of $(3) and $(17),
  respectively (b)
11  63  
Pension plan termination, net of taxes of $(669) and $0, respectively
2,516    
Other comprehensive income2,527  63  
Balance at end of period$(939) $(2,467) 

(a) Unrealized gains (losses) are reclassified to earnings as underlying cash interest payments are made. We expect to recognize a loss of $0.1 million, net of deferred taxes, over the next twelve months related to designated cash flow hedges based on their fair values at December 31, 2019.
(b) Amortization of actuarial losses out of accumulated comprehensive loss are included in the computation of net periodic pension expense. See Note 13 for additional information.
(c) The other adjustments relate to changes in the effective tax rate.

20


17. REVENUE RECOGNITION

Refer to Note 18 to our consolidated financial statements included in the Annual Report for a description of our disaggregation of revenues. Disaggregation of revenues reconciled to our reportable segments is as follows (in thousands):

Three Months Ended December 31, 2019Nine Months Ended December 31, 2019
Industrial ProductsSpecialty ChemicalsTotalIndustrial ProductsSpecialty ChemicalsTotal
Build-to-order$19,955  $  $19,955  $61,196  $  $61,196  
Book-and-ship28,718  35,043  63,761  113,598  112,579  226,177  
Net revenues$48,673  $35,043  $83,716  $174,794  $112,579  $287,373  

Three Months Ended December 31, 2018Nine Months Ended December 31, 2018
Industrial ProductsSpecialty ChemicalsTotalIndustrial ProductsSpecialty ChemicalsTotal
Build-to-order$17,917  $  $17,917  $51,238  $  $51,238  
Book-and-ship25,735  33,836  59,571  101,001  106,437  207,438  
Net revenues$43,652  $33,836  $77,488  $152,239  $106,437  $258,676  

Contract liabilities, which are included in accrued and other current liabilities in our condensed consolidated balance sheets were as follows (in thousands):

Balance at April 1, 2019:$2,337  
Revenue recognized during the period(442) 
New contracts during the period942  
Balance at December 31, 2019$2,837  


21


18. SEGMENTS

As discussed in Note 19 to our consolidated financial statements in the Annual Report, we conduct our operations through two business segments based on type of product and how we manage the business: Industrial Products and Specialty Chemicals.

Three Months Ended December 31, 2019
(in thousands)Industrial ProductsSpecialty ChemicalsSubtotal - Reportable SegmentsEliminations and OtherTotal
Revenues, net$48,673  $35,043  $83,716  $  $83,716  
Operating income8,643  5,414  14,057  (3,569) 10,488  
Three Months Ended December 31, 2018
(in thousands)Industrial ProductsSpecialty ChemicalsSubtotal - Reportable SegmentsEliminations and OtherTotal
Revenues, net$43,652  $33,836  $77,488  $  $77,488  
Operating income8,059  4,574  12,633  (3,212) 9,421  

Nine Months Ended December 31, 2019
(in thousands)Industrial ProductsSpecialty ChemicalsSubtotal - Reportable SegmentsEliminations and OtherTotal
Revenues, net$174,794  $112,579  $287,373  $  $287,373  
Operating income42,099  19,179  61,278  (10,346) 50,932  
Nine Months Ended December 31, 2018
(in thousands)Industrial ProductsSpecialty ChemicalsSubtotal - Reportable SegmentsEliminations and OtherTotal
Revenues, net$152,239  $106,437  $258,676  $2  $258,678  
Operating income36,164  17,205  53,369  (9,000) 44,369  





22


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our continuing operations financial condition and results of operations should be read together with our condensed consolidated financial statements and related notes included in this Quarterly Report, as well as our consolidated financial statements and related notes for the fiscal year ended March 31, 2019, included in our Annual Report. This discussion and analysis contains forward-looking statements based on current expectations relating to future events and our future performance that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements” below. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those risk factors set forth in our Annual Report and in this Quarterly Report.

Overview

We are a diversified industrial growth company with well-established, scalable platforms and domain expertise across two segments: Industrial Products and Specialty Chemicals. Our broad portfolio of leading products provides performance optimizing solutions to our customers. Our products and systems help contractors do their jobs better, faster and easier; make buildings safer and more aesthetically pleasing; protect valuable assets from corrosion; and improve the reliability of mission critical equipment. Our products include mechanical products for HVAC/R, sealants, architecturally-specified building products and high-performance specialty lubricants. The markets that we serve include HVAC/R, architecturally-specified building products, general industrial, plumbing, energy, rail and mining. Our manufacturing operations are concentrated in the U.S. and Canada, and we have distribution operations in Australia, Canada and the United Kingdom ("U.K."). Our products are sold directly or through designated channels both domestically and internationally.

Many of our products are used to protect the capital assets of our customers that are expensive to repair or replace and are critical to their operations. We have a source of recurring revenue from end users' maintenance, repair and overhaul activities and the consumable nature of many of our products. We also provide some custom and semi-custom products that strengthen and enhance our customer relationships. The reputation of our product portfolio is built on more than 100 well-respected brand names, such as RectorSeal No. 5, Kopr Kote, KATS Coatings, Jet-Lube Extreme, Smoke Guard, Safe-T-Switch, Metacaulk, Balco, Whitmore, Air Sentry, Oil Safe, Deacon, AC Leak Freeze and Greco Aluminum Railings.

As previously disclosed, during the quarter ended December 31, 2017, we committed to a plan to divest our Strathmore Products business (the "Coatings business"). This determination resulted in the reclassification of the assets comprising that business to assets held-for-sale and a corresponding adjustment to our consolidated statements of operations to reflect discontinued operations for all periods presented. During the quarter ended September 30, 2018, we received an aggregate of $6.9 million for the sale of assets that related to our Coatings business in multiple transactions. To assist readers in comparing current period results to the prior period results, this sale of assets resulted in gains on disposal of $6.9 million due to write-downs of long-lived assets in prior periods, which gain was recognized in the quarter ended September 30, 2018. In addition, during the quarter ended September 30, 2018, the tax benefits associated with the divestiture of the Coating business were realized by us and resulted a one-time operating cash inflow of $10.4 million. See the Statements of Cash Flows, Note 3 and Note 15 to the condensed consolidated financial statements included in this Quarterly Report for additional information.

RESULTS OF OPERATIONS

The following discussion provides an analysis of our condensed consolidated results of continuing operations and results for each of our segments.

The operations of Petersen have been included in our consolidated results of operations and in the operating results of our Industrial Products segment since April 2, 2019, the effective date of the acquisition. The operations of MSD have been included in our consolidated results of operations and in the operating results of our Industrial Products segment since January 31, 2019, the effective date of the acquisition. All acquisitions are described in Note 2 to our condensed consolidated financial statements included in this Quarterly Report.


23


Revenues, net

Three Months Ended December 31,
(Amounts in thousands)20192018
Revenues, net$83,716  $77,488  



Nine Months Ended December 31,
(Amounts in thousands)20192018
Revenues, net$287,373  $258,678  

Net revenues for the three months ended December 31, 2019 increased $6.2 million, or 8.0%, as compared with the three months ended December 31, 2018. The increase was primarily due to recent acquisitions ($3.6 million) and increased sales volumes into the plumbing ($1.9 million), general industrial ($1.2 million) and HVAC/R ($1.0 million) end markets, partially offset by declines in architecturally-specified building products ($0.7 million) and energy ($0.4 million) end markets.

Net revenues for the nine months ended December 31, 2019 increased $28.7 million, or 11.1%, as compared with the nine months ended December 31, 2018. The increase was primarily due to recent acquisitions ($11.6 million), increased sales volumes into the HVAC/R ($9.0 million), plumbing ($3.1 million), architecturally-specified building products ($2.0 million), energy ($1.5 million), mining ($1.2 million) and rail ($0.9 million) end markets.

Gross Profit and Gross Profit Margin

Three Months Ended December 31,
(Amounts in thousands, except percentages)20192018
Gross profit$37,691  $34,228  
Gross profit margin45.0 %44.2 %
Nine Months Ended December 31,
(Amounts in thousands, except percentages)20192018
Gross profit$132,330  $118,525  
Gross profit margin46.0 %45.8 %

Gross profit for the three months ended December 31, 2019 increased $3.5 million, or 10.1%, as compared with the three months ended December 31, 2018. The increase was primarily a result of increased sales and recent acquisitions. Gross profit margin of 45.0% for the three months ended December 31, 2019 increased as compared with 44.2% for the three months ended December 31, 2018. The increase in gross profit margin is due to the recent acquisitions and leverage from increased sales, partially offset by negative mix on architecturally-specified building products.

Gross profit for the nine months ended December 31, 2019 increased $13.8 million, or 11.6%, as compared with the nine months ended December 31, 2018. The increase in gross profit was due to increased sales, recent acquisitions and a $0.8 million gain on sales of property, plant and equipment in the current period, partially offset by a $2.6 million gain on sales of property, plant and equipment in the prior year that did not recur. Gross profit margin of 46.0% for the nine months ended December 31, 2019 increased slightly as compared with the nine months ended December 31, 2018, as the positive impact of acquisitions and leverage from increased sales were mostly offset by the negative net impact from the current and prior year sales of property, plant and equipment.

24


Operating Expenses

Three Months Ended December 31,
(Amounts in thousands, except percentages)20192018
Operating expenses$27,203  $24,807  
Operating expenses as a percentage of revenues, net32.5 %32.0 %
Nine Months Ended December 31,
(Amounts in thousands, except percentages)20192018
Operating expenses$81,398  $74,156  
Operating expenses as a percentage of revenues, net28.3 %28.7 %

Operating expenses for the three months ended December 31, 2019 increased $2.4 million, or 9.7%, as compared with the three months ended December 31, 2018. The increases in both operating expenses and operating expenses as a percentage of revenues were primarily due to increased personnel-related expenses, as well as additional selling, general and administrative costs related to acquired businesses.

Operating expenses for the nine months ended December 31, 2019 increased $7.2 million, or 9.8%, as compared with the nine months ended December 31, 2018. The increase in operating expenses was primarily due to increased personnel-related expenses, as well as additional $0.9 million selling, general and administrative costs related to acquired businesses and increased professional fees. The decrease in operating expenses as a percentage of sales was attributable to leverage on increased sales.

Operating Income

Three Months Ended December 31,
(Amounts in thousands, except percentages)20192018
Operating income$10,488  $9,421  
Operating margin12.5 %12.2 %
Nine Months Ended December 31,
(Amounts in thousands, except percentages)20192018
Operating income$50,932  $44,369  
Operating margin17.7 %17.2 %

Operating income for the three months ended December 31, 2019 increased $1.1 million, or 11.3%, as compared with the three months ended December 31, 2018, primarily as a result of the increase in gross profit, partially offset by an increase in operating expenses, as discussed above.

Operating income for the nine months ended December 31, 2019 increased $6.6 million, or 14.8%, as compared with the nine months ended December 31, 2018, primarily as a result of the increase in gross profit, partially offset by an increase in operating expenses, as discussed above.

Other Income and Expense

Net interest expense of $0.3 million and $1.1 million for the three and nine months ended December 31, 2019, respectively, were comparable to net interest expense for the three and nine months ended December 31, 2018.

Other income (expense), net was a net loss of $0.8 million for the three months ended December 31, 2019 as compared with net income of $0.3 million for the three months ended December 31, 2018. The decrease was primarily due to a lease termination loss of $0.5 million and an increase in losses arising from transactions in currencies other than our sites' functional currencies. Other income (expense), net was a net loss of $8.3 million for the nine months ended December 31, 2019 as compared with net income of $1.2 million for the nine months ended December 31, 2018. The decrease was due to $7.0 million
25


of expenses recognized in connection with the termination of our U.S. defined benefit pension plan, an increase in losses arising from transactions in currencies other than our sites' functional currencies and a lease termination loss of $0.5 million.

Provision for Income Taxes and Effective Tax Rate

For the three months ended December 31, 2019, we earned $9.4 million from continuing operations before taxes and provided for income taxes of $2.1 million, resulting in an effective tax rate of 22.2%. For the nine months ended December 31, 2019, we earned $41.5 million from continuing operations before taxes and provided for income taxes of $10.1 million, resulting in an effective tax rate of 24.3%. The provision for income taxes differed from the statutory rate for the three and nine months ended December 31, 2019, primarily due to the provision for GILTI, adjustments related to foreign items, excess tax deductions related to stock compensation and adjustments related to income tax returns.

For the three months ended December 31, 2018, we earned $9.5 million from continuing operations before taxes and provided for income taxes of $3.5 million, resulting in an effective tax rate of 36.7%. For the nine months ended December 31, 2018, we earned $44.4 million from continuing operations before taxes and provided for income taxes of $12.0 million, resulting in an effective tax rate of 27.0%. The provision for income taxes differed from the statutory rate for the three and nine months ended December 31, 2018 primarily due to adjustments related to federal and foreign income tax returns.

We are currently under audit for our U.S. federal income tax return for the fiscal years ended March 31, 2017 and 2016. We have not been notified of any potential adjustments. We are currently under audit by a state for the fiscal years ended March 31, 2018 and 2017.

Business Segments

We conduct our operations through two business segments based on type of product and how we manage the business. We evaluate segment performance and allocate resources based on each segment's operating income. The key operating results for our two segments are discussed below.

Industrial Products Segment Results

Industrial Products includes specialty mechanical products, fire and smoke protection products, architecturally-specified building products and storage, filtration and application equipment for use with our specialty chemicals and other products for general industrial application. 

Three Months Ended December 31,
(Amounts in thousands)20192018
Revenues, net$48,673  $43,652  
Operating income8,643  8,059  
  Operating margin17.8 %18.5 %
Nine Months Ended December 31,
(Amounts in thousands)20192018
Revenues, net$174,794  $152,239  
Operating income42,099  36,164  
  Operating margin24.1 %23.8 %

Net revenues for the three months ended December 31, 2019 increased $5.0 million, or 11.5%, as compared with the three months ended December 31, 2018. The increase was primarily due to recent acquisitions ($3.6 million) and increased sales volumes into the plumbing ($1.6 million) and HVAC/R ($1.1 million) end markets, partially offset by a decline in the architecturally-specified building products ($0.9 million) end market.

Net revenues for the nine months ended December 31, 2019 increased $22.6 million, or 14.8%, as compared with the nine months ended December 31, 2018. The increase was due primarily to recent acquisitions ($11.6 million) and increased sales volumes into the HVAC/R ($9.2 million), plumbing ($2.7 million) and general industrial ($0.9 million) end markets, partially offset by a decline in the rail ($1.5 million) end market.

26


Operating income for the three months ended December 31, 2019 increased $0.6 million, or 7.2%, as compared with the three months ended December 31, 2018. The increase was primarily due to contributions by recent acquisitions, partially offset by a decline in architecturally-specified building products and negative mix in architecturally-specified building products.

Operating income for the nine months ended December 31, 2019 increased $5.9 million, or 16.4%, as compared with the nine months ended December 31, 2018. The increase was due primarily to contributions by recent acquisitions and increased sales, partially offset by increased personnel related expenses and a $0.5 million gain on the sale of property, plant and equipment in the prior year that did not recur.

Specialty Chemicals Segment Results

Specialty Chemicals is comprised of pipe thread sealants, firestopping sealants and caulks, adhesives/solvent cements, lubricants and greases, drilling compounds, anti-seize compounds, chemical formulations and degreasers and cleaners.

Three Months Ended December 31,
(Amounts in thousands)20192018
Revenues, net$35,043  $33,836  
Operating income5,414  4,574  
  Operating margin15.4 %13.5 %
Nine Months Ended December 31,
(Amounts in thousands)20192018
Revenues, net$112,579  $106,437  
Operating income19,179  17,205  
  Operating margin17.0 %16.2 %

Net revenues for the three months ended December 31, 2019 increased $1.2 million, or 3.6%, as compared with the three months ended December 31, 2018.  The increase is due primarily to increased sales into the rail end market, as well as smaller increases in the plumbing and mining end markets, partially offset by a decline in the energy end market.

Net revenues for the nine months ended December 31, 2019 increased $6.1 million, or 5.8%, as compared with the nine months ended December 31, 2018.  The increase was primarily due to increased sales volumes into the rail ($2.3 million), energy ($1.5 million), architecturally-specified building products ($1.5 million) and mining ($1.2 million) end markets, slightly offset by a decline in the general industrial end market.

Operating income for the three months ended December 31, 2019 increased $0.8 million, or 18.4%, as compared with the three months ended December 31, 2018. The increase was primarily due to increased sales and favorable sales mix.

Operating income for the nine months ended December 31, 2019 increased $2.0 million, or 11.5%, as compared with the nine months ended December 31, 2018. The increase was primarily due to increased sales and favorable sales mix, partially offset by the negative net impact from the current and prior year sales of property, plant and equipment and increased personnel-related expenses.

LIQUIDITY AND CAPITAL RESOURCES

Cash Flow Analysis 

Nine Months Ended December 31,
(Amounts in thousands)20192018
Net cash provided by operating activities, continuing operations$60,353  $58,281  
Net cash (used in) provided by investing activities, continuing operations(18,193) 627  
Net cash used in financing activities(29,293) (54,176) 

27


Existing cash, cash generated by continuing operations and borrowings available under our Revolving Credit Facility are our primary sources of short-term liquidity.  We monitor the depository institutions that hold our cash and cash equivalents on a regular basis, and we believe that we have placed our deposits with creditworthy financial institutions.  Our sources of operating cash generally include the sale of our products and services and the conversion of our working capital, particularly accounts receivable and inventories.  Our cash balance (including cash and cash equivalents) at December 31, 2019 was $39.9 million, as compared with $26.7 million at March 31, 2019.

For the nine months ended December 31, 2019, our cash provided by operating activities from continuing operations was $60.4 million, as compared with $58.3 million for nine months ended December 31, 2018. 

Working capital provided cash for the nine months ended December 31, 2019 due to lower accounts receivable ($10.1 million) and lower prepaid expenses and other current assets ($3.2 million), partially offset by higher inventory ($5.1 million).
Working capital provided cash for the nine months ended December 31, 2018 due to lower accounts receivable ($12.5 million) and higher accounts payable and other current liabilities ($1.8 million), partially offset by higher inventories ($7.7 million) and higher prepaid expenses and other current assets ($2.3 million).

Cash flows used in investing activities of continuing operations during the nine months ended December 31, 2019 were $18.2 million as compared with $0.6 million of cash provided by investing activities of continuing operations during the nine months ended December 31, 2018. During the nine months ended December 31, 2019, we paid $11.8 million for the acquisition of Petersen and had no acquisitions during the nine months ended December 31, 2018. Capital expenditures during the nine months ended December 31, 2019 were $7.6 million, an increase of $2.8 million as compared with the nine months ended December 31, 2018.  Our capital expenditures have been focused on continuous improvement, automation, maintenance and new products. Proceeds from the sale of assets during the nine months ended December 31, 2019 were $1.2 million as compared with $5.4 million of proceeds during the nine months ended December 31, 2018. 

Cash flows used in financing activities during the nine months ended December 31, 2019 were $29.3 million as compared with $54.2 million for the nine months ended December 31, 2018.  Cash outflows during the nine months ended December 31, 2019 included $20.4 million of net debt repayments (as discussed in Note 7 to our condensed consolidated financial statements included in this Quarterly Report), $6.1 million of dividend payments and $0.8 million for the repurchase of shares under our share repurchase programs (as discussed in Note 11 to our condensed consolidated financial statements included in this Quarterly Report). Cash outflows during the nine months ended December 31, 2018 included $12.4 million of net debt repayments and $40.7 million for the repurchase of shares under our share repurchase programs.

We believe that available cash and cash equivalents, cash flows generated through continuing operations and cash available under our Revolving Credit Facility will be sufficient to meet our liquidity needs, including capital expenditures, for at least the next 12 months.

Acquisitions and Dispositions

We regularly evaluate acquisition opportunities of various sizes.  The cost and terms of any financing to be raised in conjunction with any acquisition, including our ability to raise capital, is a critical consideration in any such evaluation. Note 2 to our condensed consolidated financial statements included in this Quarterly Report contains a discussion of the recent acquisitions.

Financing

Credit Facilities

See Note 7 to our condensed consolidated financial statements included in this Quarterly Report for a discussion of our indebtedness.  We were in compliance with all covenants as of December 31, 2019.

We have entered into an interest rate swap agreement to hedge our exposure to variable interest payments related to our indebtedness.  This agreement is more fully described in Note 9 to our condensed consolidated financial statements included in this Quarterly Report and in “Item 3. Quantitative and Qualitative Disclosures about Market Risk” below.


28


Off-Balance Sheet Arrangements

As of December 31, 2019, we did not have any off-balance sheet arrangements that we believe have or are reasonably likely to have a material adverse effect on our financial condition or results of operations.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Management’s discussion and analysis of financial condition and results of operations are based on our condensed consolidated financial statements and related footnotes contained within this Quarterly Report. Our critical accounting policies used in the preparation of our condensed consolidated financial statements were discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report. No significant changes to these policies, as described in our Annual Report, have occurred in the nine months ended December 31, 2019.

The process of preparing condensed consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions to determine certain of the assets, liabilities, revenues and expenses.  These estimates and assumptions are based upon what we believe is the best information available at the time of the estimates or assumptions.  The estimates and assumptions could change materially as conditions within and beyond our control change.  Accordingly, actual results could differ materially from those estimates.

Based on an assessment of our accounting policies and the underlying judgments and uncertainties affecting the application of those policies, we believe that our condensed consolidated financial statements provide a meaningful and fair perspective of our consolidated financial condition and results of operations.  This is not to suggest that other general risk factors, such as changes in worldwide demand, changes in material costs, performance of acquired businesses and others, could not adversely impact our consolidated financial condition, results of operations and cash flows in future periods. See “Cautionary Note Regarding Forward-Looking Statements” below.

ACCOUNTING DEVELOPMENTS

We have presented the information about pronouncements not yet implemented in Note 1 to our condensed consolidated financial statements included in this Quarterly Report.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements appearing in this Quarterly Report constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include expected restructuring charges and the results of the restructuring, financial projections, statements of plans and objectives for future operations, statements of future economic performance and statements of assumptions relating thereto. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “expects,” “plans,” “anticipates,” “estimates,” “believes,” “potential,” “projects,” “forecasts,” “intends,” or the negative thereof or other comparable terminology. Forward-looking statements may include, but are not limited to, statements that relate to, or statements that are subject to risks, contingencies or uncertainties that relate to:
 
our business strategy;
future levels of revenues, operating margins, income from operations, net income or earnings per share;
anticipated levels of demand for our products and services;
future levels of research and development, capital, environmental or maintenance expenditures;
our beliefs regarding the timing and effects on our business of health and safety, tax, environmental or other legislation, rules and regulations;
the success or timing of completion of ongoing or anticipated capital, restructuring or maintenance projects;
expectations regarding the acquisition or divestiture of assets and businesses;
our ability to obtain appropriate insurance and indemnities;
the potential effects of judicial or other proceedings, including tax audits, on our business, financial condition, results of operations and cash flows;
the anticipated effects of actions of third parties such as competitors, or federal, foreign, state or local regulatory authorities, or plaintiffs in litigation; and
the effective date and expected impact of accounting pronouncements.

Forward-looking statements involve risks, uncertainties and assumptions. Actual results may differ materially from those expressed in these forward-looking statements for a number of important factors, including those listed under “Risk Factors” in
29


our Annual Report and in this Quarterly Report. You should not put undue reliance on any forwarding-looking statements in this Quarterly Report.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to market risk from changes in interest rates and foreign currency exchange rates, which may adversely affect our consolidated financial position and results of operations.  We seek to minimize the risk associated with changes in interest rates through regular operating and financing activities and, when deemed appropriate, through the use of an interest rate swap.  It is our policy to enter into interest rate swaps only to the extent considered necessary to meet our risk management objectives.  We do not purchase, hold or sell derivative financial instruments for trading or speculative purposes.

Variable Rate Indebtedness

We are subject to interest rate risk on our variable rate indebtedness. Fluctuations in interest rates have a direct effect on interest expense associated with our outstanding indebtedness.  As of December 31, 2019, we had no outstanding variable rate indebtedness, after consideration of our interest rate swap.  We manage or hedge interest rate risks related to our current borrowings by means of an interest rate swap agreement.  At December 31, 2019, we had an interest rate swap agreement that covered 100.0% of our $11.0 million total outstanding indebtedness. Each quarter point change in interest rates would result in a negligible change in our interest expense on an annual basis.

We may also be exposed to credit risk in derivative contracts we may use.  Credit risk is the failure of the counterparty to perform under the terms of the derivative contract.  If the fair value of a derivative contract is positive, the counterparty will owe us, which creates credit risk for us.  If the fair value of a derivative contract is negative, we will owe the counterparty and, therefore, do not have credit risk.  We have sought to minimize the credit risk in derivative instruments by entering into transactions with high-quality counterparties.

Foreign Currency Exchange Rate Risk

We conduct a small portion of our operations outside of the U.S. in currencies other than the U.S. dollar. Our non-U.S. operations are conducted primarily in their local currencies, which are also their functional currencies, and include the British pound, Canadian dollar and Australian dollar.  Foreign currency exposures arise from translation of foreign-denominated assets and liabilities into U.S. dollars and from transactions denominated in a currency other than a non-U.S. operation’s functional currency. We recognized foreign currency transaction net (losses) gains of $(0.4) million and $0.2 million for the three months ended December 31, 2019 and 2018, respectively, and $(0.6) million and $0.7 million for the nine months ended December 31, 2019 and 2018, respectively, which are included in other (expense) income, net on our condensed consolidated statements of income. We realized a net (loss) gain associated with foreign currency translation of $1.7 million and $(1.6) million for the three months ended December 31, 2019 and 2018, respectively, and $1.3 million and $(3.0) million for the nine months ended December 31, 2019 and 2018, respectively, which are included in accumulated other comprehensive income (loss).

Based on a sensitivity analysis at December 31, 2019, a 10% change in the foreign currency exchange rates for the three and nine months ended December 31, 2019 would have impacted our net earnings by a negligible amount.  This calculation assumes that all currencies change in the same direction and proportion relative to the U.S. dollar and that there are no indirect effects, such as changes in non-U.S. dollar sales volumes or prices.

30


Item 4. Controls and Procedures.

Disclosure Controls and Procedures

The Company's management, with the participation of the Company's Chief Executive Officer and Executive Vice President and Chief Financial Officer, has evaluated the effectiveness of the Company's disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, (the "Exchange Act")) as of the end of the period covered by this Quarterly Report. Based on such evaluation, the Company's Chief Executive Officer and Executive Vice President and Chief Financial Officer have concluded that, as of the end of such period, the Company's disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the quarter ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

31


PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

The disclosure contained in Note 14 to our condensed consolidated financial statements included in “Item 1. Financial Statements” of this Quarterly Report is incorporated by reference into this “Item 1. Legal Proceedings.” In addition to the foregoing, we and our subsidiaries are from time to time named defendants in certain lawsuits incidental to our business, including product liability claims that are insured, subject to applicable deductibles, and are involved from time to time as parties to governmental proceedings, all arising in the ordinary course of business. Although the outcome of lawsuits or other proceedings involving us and our subsidiaries cannot be predicted with certainty, and the amount of any liability that could arise with respect to such lawsuits or other proceedings cannot be predicted accurately, management does not currently expect the amount of any liability that could arise with respect to these matters, either individually or in the aggregate, to have a material adverse effect on our financial position, results of operations or cash flows.

Item 1A. Risk Factors.

There are numerous factors that affect our business and results of operations, many of which are beyond our control. In addition to other information set forth in this Quarterly Report, careful consideration should be given to “Item 1A. Risk Factors” in Part I and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II of our Annual Report, which contain descriptions of significant factors that may cause the actual results of operations in future periods to differ materially from those currently expected or desired.

There have been no material changes in the risk factors discussed in our Annual Report and subsequent SEC filings. The risks described in this Quarterly Report, our Annual Report and in our other SEC filings or press releases from time to time are not the only risks we face. Additional risks and uncertainties are currently deemed immaterial based on management’s assessment of currently available information, which remains subject to change; however, new risks that are currently unknown to us may arise in the future that could materially adversely affect our business, financial condition, results of operations or cash flows.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Note 11 to our condensed consolidated financial statements included in “Item 1. Financial Statements” of this Quarterly Report includes a discussion of our share repurchase programs. On November 7, 2018, we announced that our Board of Directors authorized a new program allowing us to repurchase shares of our common stock up to an aggregate market value of $75.0 million during a two-year period. The program may be limited or terminated at any time. During the three and nine months ended December 31, 2019, 12,494 shares were repurchased under this program for an aggregate amount of $0.8 million. As of December 31, 2019, 243,644 shares of our common stock had been repurchased under the new program since its inception for an aggregate of $12.6 million.


Period
Total Number of
Shares Purchased
Average Price
Paid per Share
Total Number of
Shares Purchased as
Part of Publicly
Announced Program
Maximum Number 
of Shares
(or Approximate 
Dollar Value)
That May Yet Be
Purchased
Under the Program
(in millions)
October 1 - 3130,132  (a)$66.09  12,494  $62.4  
November 1 - 30—  —  —  62.4  
December 1 - 31—  —  —  62.4  
Total30,132  12,494  


(a) Includes 17,638 shares tendered by employees to satisfy minimum tax withholding amounts for restricted share vesting at an average
price per share of $66.92.

32


Item 6. Exhibits

Exhibit No.
Description
3.1
3.2
31.1*
31.2*
32.1**
32.2**
101.INSXBRL Instance Document
101.SCHInline XBRL Taxonomy Extension Schema
101.CALInline XBRL Taxonomy Extension Calculation LinkBase Document
101.DEFInline XBRL Taxonomy Extension Definition LinkBase Document
101.LABInline XBRL Taxonomy Extension Label LinkBase Document
101.PREInline XBRL Taxonomy Extension Presentation LinkBase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.NS)

_________________________
* Filed herewith
** Furnished herewith
        

33


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CSW INDUSTRIALS, INC.
February 4, 2020 /s/ Joseph B. Armes
Joseph B. Armes
Chief Executive Officer
(Principal Executive Officer)
February 4, 2020 /s/ Greggory W. Branning
Greggory W. Branning
Chief Financial Officer
(Principal Financial Officer)

34
Document

EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Joseph B. Armes, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended December 31, 2019 of CSW Industrials, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purpose in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 4, 2020
 /s/ Joseph B. Armes
Joseph B. Armes
Chief Executive Officer
(Principal Executive Officer)


Document

EXHIBIT 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Greggory W. Branning, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended December 31, 2019 of CSW Industrials, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purpose in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 4, 2020

 /s/ Greggory W. Branning
Greggory W. Branning
Chief Financial Officer
(Principal Financial Officer)


Document

EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Joseph B. Armes, Chief Executive Officer of CSW Industrials, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) the Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Quarterly Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company.
Date: February 4, 2020

 /s/ Joseph B. Armes
Joseph B. Armes
Chief Executive Officer
(Principal Executive Officer)


Document

EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Greggory W. Branning, Chief Financial Officer of CSW Industrials, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) the Quarterly Report on Form 10-Q of the Company for the quarter ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Quarterly Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company.
Date: February 4, 2020

 /s/ Greggory W. Branning
Greggory W. Branning
Chief Financial Officer
(Principal Financial Officer)